CheckMan Stock Market Overview

Burger King's parent company is doing a joint venture with a Chinese investment firm to inject new capital to expand the burger chain's business in China.

New York, New York--(Newsfile Corp. - November 10, 2025) - If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE: INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=176578&wire=5&utm_campaign=2 or contact Joseph E. Levi, Esq.

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM).

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Avantor, Inc. (NYSE: AVTR). Shareholders who purchased shares of AVTR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Kymera Therapeutics, Inc. ( KYMR ) UBS Global Healthcare Conference 2025 November 10, 2025 11:45 AM EST Company Participants Jared Gollob - Chief Medical Officer Conference Call Participants Xiaochuan Dai - UBS Investment Bank, Research Division Presentation Xiaochuan Dai UBS Investment Bank, Research Division All right. Well, thank you, everyone, for joining us in our fireside chat with Kymera Therapeutics.

KE Holdings Inc. ( BEKE ) Q3 2025 Earnings Call November 10, 2025 7:00 AM EST Company Participants Siting Li - Investor Relations Director & Joint Company Secretary Tao Xu - CFO & Executive Director Yongdong Peng - Co-Founder, Chairman & CEO Conference Call Participants John Lam - UBS Investment Bank, Research Division Griffin Chan - Citigroup Inc., Research Division Jiong Shao - Barclays Bank PLC, Research Division Timothy Zhao - Goldman Sachs Group, Inc., Research Division Presentation Operator Hello, ladies and gentlemen. Thank you for standing by for KE Holdings, Inc. Third Quarter 2025 Earnings Conference Call.

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of James Hardie Industries plc. (NYSE: JHX).

Ionis Pharmaceuticals maintains a Buy rating as its transformation to a commercial company accelerates, driven by wholly-owned product launches and revenue growth. Q3 results highlight a revenue shift toward Ionis-owned drugs, with Tryngolza outperforming and Dawnzera launching as a differentiated HAE prophylactic. Olezarsen's strong Phase 3 data in sHTG positions IONS for a blockbuster opportunity, despite market competition and ongoing patent litigation with Arrowhead.

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX). Shareholders who purchased shares of BAX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Global X Gold Explorers ETF has outperformed VanEck Gold Miners ETF and VanEck Junior Gold Miners ETF in 2025, rising 169% year-to-date amid a strong gold bull market. GOEX offers high momentum but carries elevated risk, lower dividend, and higher expense ratios compared to GDX and GDXJ. Unlike leveraged products, GOEX avoids time decay and benefits from the inherent leverage of gold exploration and mining equities.